Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus aspirin versus placebo for vascular function and inflammation in treated HIV patients at low cardiovascular risk
RBR-39bjm4Recruiting
- Sponsor
- Hospital das Clínicas da UFPE
- Start
- May 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atorvastatin and aspirin in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital das Clínicas da UFPE. Primary endpoints: Vascular function and Inflammation. Started May 2014; status: recruiting.
02
Drugs
atorvastatinaspirin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on RBR-39bjm4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-39bjm4.